SCHEMBL14855671

SCHEMBL14855671

CCc1cccc(COCC(=O)O)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.42
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GLA P06280 1/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
PTGS2 P35354 1/20 0.36
MRGPRX4 Q96LA9 2/20 0.36
LMNA P02545 2/20 0.36
ALOX15 P16050 2/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2349654 0.85 FFAR4 (0.46) KMT2AMEN1ALDH1A1FFAR4
SCHEMBL9789585 0.82 L3MBTL1 (0.46) GABRA1GABRB2L3MBTL1GLAKMT2A
SCHEMBL11556832 0.78 ALOX15 (0.50) L3MBTL1GLAKMT2AMEN1MAPT
SCHEMBL5037414 0.77 ALDH1A1 (0.53) L3MBTL1KMT2AMEN1MAPTLMNA
SCHEMBL11076518 0.77 AKR1B1 (0.50) KAT6AGABRA1GABRB2MAPTPTGS2
SCHEMBL14855670 0.75 KAT6A (0.41) KAT6AGABRA1GABRB2MRGPRX4NLRP3
SCHEMBL22306130 0.75 GABRA1 (0.55) KAT6AGABRA1GABRB2L3MBTL1KMT2A
SCHEMBL13886097 0.74 MAOB (0.49) L3MBTL1KMT2AMAPTPTGS2ALOX15
SCHEMBL5041857 0.73 L3MBTL1 (0.45) L3MBTL1GLANPC1MRGPRX4TSHR
SCHEMBL19900523 0.72 AKR1B1 (0.59) L3MBTL1KMT2AALOX15TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD KAT6A 794/4885GABRA1 129/4885GABRB2 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.